BioCryst Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
January 10, 2022 U.S. Securities and Exchange Commission
Show full article |
This functionality is available for registred users only
|
Company — BioCryst Pharmaceuticals
-
Full nameBioCryst Pharmaceuticals, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
Share